Far Infrared Radiation Treatment for Prostate Cancer

Phase 1

• Conditions: Prostatic Neoplasms
• Interventions: Radiation: Far Infrared Radiation

• Registration Number: NCT00573820
• Lead Sponsor: GAAD Medical Research Institute Inc.

Brief Summary

A study to determine the use of far infrared radiation for the treatment of prostate cancer.

Detailed Description

Our initial assessment indicates that electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to cure a number of diseases, including prostate cancer.

Study Timeline

• Study Start: 2006-01
• Study First Submitted: 2007-12-12
• Study First Submitted QC: 2007-12-12
• Study First Posted: 2007-12-14
• Primary Completion: 2008-02
• Study Completion: 2008-12
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-14
• Last Update Posted: 2009-08-17

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 4

Inclusion Criteria

• Persons with Prostate, Bladder or Testicular Cancer.

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Far Infrared Radiation	-

Primary Outcome Measures

Name	Time	Method
The primary end point is to determine the therapeutic effects of far infrared radiation on Prostate Cancer.	2 years and 6 months

Secondary Outcome Measures

Name	Time	Method
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other types of cancer (Bladder and Testis).	2 years and 6 months

Trial Locations

Locations (1)

The Centre for Incurable Diseases; 🇨🇦 Toronto, Ontario, Canada